Ventricular Rate Control in Atrial Fibrillation: What is the Optimal Rate? The Concept of Controlling the Heart Rate Burden

Abstract

References

1. Singh BN . Morbidity and mortality in cardiovascular disorders: Impact of reduced heart rate. J Cardiovasc Pharmacol Therapeut 6:313-313, 2001

2. Kannel W , Kannel C , Paffenbarger R , Cupples A . Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J 113:1489-1489, 1987

3. Gillum R . The epidemiology of resting heart rate in a national sample of men and women: Association with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. Am Heart J 116:163-163, 1988

4. Gillman M , Kannel W , Belanger A , D'Agostino R . Influence of heart rate on mortality among persons with hypertension: The Framingham study. Am Heart J 125:1148-1148, 1993

5. Habib G . Reappraisal of the importance of heart rate as a risk factor for cardiovascular morbidity and mortality. Clin Therapeut 19 (suppl A):39-39, 1997

6. Hjalmarson A , Gilpin E , Kjekshus J , et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 65:547-547, 1990

7. Gundersen T , Gröttum P , Pedersen T , Kjekshus J , for the Norwegian Timolol Multi-center Study Group . Effect of timolol on mortality and reinfarction after acute myocardial infarction: Prognostic importance of heart rate at rest. Am J Cardiol 58:20-20, 1986

8. Kjekshus J . Importance of heart rate in determining betablocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 57:43F-43F, 1986

9. The Beta-blocker Evaluation of Survival Trial Investigators . A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344:1659-1659, 2001

10.

10. Kendall MJ , Lynch KP , Hjalmarson A , Kjekshus J . Betablockers and sudden cardiac death. Ann Intern Med 123(5):358-358, 1995

11.

11. Hjalmarson A . Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol 80(9B):35J-35J, 1997

12.

12. Palatini P , Casiglia E , Julius S , Pesina AC . High heart rate. A risk factor for cardiovascular death in elderly men. Arch Int Med 159:585-585, 1999

13.

13. Palatini P . Elevated heart rate as a predictor of increased cardiovascular morbidity. J Hypertens. 17(suppl 3):S3-S3, 1999

14.

14. Shinbane J , Wood M , Jensen D , et al. Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. J Am Coll Cardiol 29:709-709, 1997

15.

15. Redfield M , Kay G , Jenkins L , et al. Tachycardia-related cardiomyopathy: A common cause of ventricular dysfunction in patients with referred for atrioventricular ablation. Mayo Clin Proc 75:790-790, 2000

16.

16. Pinter A , Dorian P , Paquette M , et al. Left ventricualr performance during acute rate control in atrial fibrillation: The importance of heart rate and agents used. J Pharmacol Therapeut 8:17-24, 2003

17.

17. Benjamin EJ , Wolf PA , D'Agostino RB , et al. Impact of atrial fibrillation on the risk of death. The Framingham Heart Study. Circulation 98:946-946, 1998

18.

18. Pozolli, Cioffi G , Traversi E , et al. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: A prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 32:197-204, 1998

19.

19. Stevenson WG , Stevenson LW . Atrial fibrillation in heart failure. N Engl J Med 34:910-910, 1999

20.

20. Tsang TSM , Gersh BJ . Atrial fibrillation: An old disease, a new epidemic. Am J Med 113:232-232, 2002

21.

21. Braunwald E . Shattuck lecture . Cardiovascular medicine at the turn of the turn of millenium: Triumphs, concerns and opportunities. N Engl J Med 337:1360-1360, 1997

22.

22. Scheinman MM . Atrial fibrillation and congestive heart failure: The intersection of two common diseases. Circulation 98:949-949, 1998

23.

23. Grogan M , Smith HC , Gersh BC , Wood DC . Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have dilated cardiomyopathy. Am J Cardiol 69:1570-1570, 1992

24.

24. Farshi R , Kistner D , Sarma JSM , Longmate JA , Singh BN . Ventricualr rate control in chronic atrial fibrillation during daily activity and programmed exercise. A crossover openlabel study of five drug regimens. J Am Coll Cardiol 33: 304-304, 1999

25.

25. Palatini P . Need for revision of the normal limits of resting heart rate. Hypertension 33:622-622, 1999